
Christine Hodgdon
@christeeny513
Stage IV Breast Cancer Survivor & Advocate treated at Johns Hopkins #BCSM. Extroverted introvert who loves nature & traveling. Co-founder of GRASP @grasptweets
ID: 867159448065912832
http://www.graspcancer.org 23-05-2017 23:24:58
2,2K Tweet
3,3K Followers
2,2K Following


In 2022, Janice Cowden , Dear Dr. Researcher, PhD, & I sat together to hear the much anticipated DESTINY-Breast 04 trial results. As cancer survivors, when we see data, we see the patients behind the data, we ARE the patients behind the data, & weāre grateful to still be here! #ASCO25


We are delighted to see Christine Hodgdon, patient advocate co-founder of GRASP and member of the BIG-PPI collaboration, participating in her first BIG-NCTN Annual Meeting. Christine Hodgdon National Cancer Institute The Breast Cancer Research Foundation #ASCO25

šļøASCO TECAG #ASCO25 #Trainees learn #advocacy early! "Advocacy 101: How to Make a Difference for Your Patients and Your Practice" with Christine Hodgdon #DrBrianPersing Ivy Riano, M.D. Jasmine Kamboj, MD, FASCO ā°5/31 12:30 PM - 1:15 PMš Hall C #OncMedEdCoP ASCO Hem-Onc Fellows Network



This night owl finally made it to an #oncoalert 5K at #ASCO25. It was actually 4 miles, but whoās counting š . Grateful to have running partners Drs Dionisia Quiroga, DO, PhD & Maggy Gatti-Mays!! #bcsm



"All treatments are 'tolerable' ...if you don't ask people who they feel." Dr Dawn Hershman getting #ASCO25's highest honor, the @asco David Karnofsky Science of Oncology Award for fostering a new world of patient-centered research and care.


Advocacy 101- wonderful discussions around Advocacy and Policy at the Trainee and Early Career Lounge. Itās amazing to see how much our trainees and early career folks are engaged in this space. šššš #advocacy #ASCO25 Christine Hodgdon Ivy Riano, M.D. Brian Persing


The new #SAPPHO study, led by Dana-Farberās Breast Oncology Center & Translational Breast Cancer Research Consortium, is evaluating a novel treatment approach for HER2+ #MetastaticBreastCancer. The study will help investigators understand if giving sequential treatments is safe and effective for patients with newly diagnosed HER2+ #MBC,



Just your average night at #ASCO25 ā The Eric J. Small, MD, FASCO & CMO Julie Gralow tearing up the dance floor at the Presidentās Reception!




#HotTopicAlert ā Liquid biopsy in ER+/ZHER2- metastatic breast cancer to evaluate treatment resistance with GRASP scientist Lorenzo Gerratana. Join us on June 11 at 2:00pm. Register today at graspcancer.org/events/asco25-⦠#asco #asco2025 #bcsm #registertoday #GRASPPosters #GRASPatASCO


Dr Abdou (Yara Abdou, MD, MSCR) will discuss the higher risk of recurrence in Black pts with HR+ early stage breast cancer & the need to improve outcomes & address these racial disparities. She is wonderful, join us!

Join UNC's Assistant Professor of Medicine Yara Abdou, MD, MSCR on June 12 as she discusses racial inequities and HER2-Negative breast cancer. This group will fill up fast, so make sure you register today graspcancer.org/events/asco25-ā¦ā¦ #asco2025 #bcsm #registertoday #GRASPPosters #GRASPatASCO


Join a small group discussion on HER2-ultralow scoring, AI-assisted pathology, and T-DXd (Enhertu) response in this patient cohort. Dionisia Quiroga, DO, PhD is excels at translating complex science into clear, accessible language. #bcsm


Join leading breast cancer oncologist, Stephanie Graff, MD, FACP, FASCO, this week for a deep dive into the real-world impact of ADCs in HER2-negative metastatic breast cancer. This session will fill up fast so register today! graspcancer.org/events/asco25-⦠#bcsm #registertoday #GRASPPosters #her2 #adcs
